PRELIMINARY IMMUNOGENICITY RESULTS FROM THE DOSE ESCALATION PHASE OF A FIRST-IN-HUMAN STUDY OF THE MRNA-BASED CANCER VACCINE CVGBM IN PATIENTS WITH NEWLY DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA

This article has no abstract
Epistemonikos ID: 5f44d0566d6272edcfa75a43712957e081758964
First added on: Jun 07, 2025